Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (DRKS00032782) titled 'Long-term follow-up of patients with adenocarcinoma of the Esophagus treated with perioperative chemotherapy (FLOT Protocol) or neoadjuvant chemoradiation (CROSS Protocol) (ESOFU Observational Study)' on July 31.

Study Type: observational

Study Design: Allocation: Masking: Control: Assignment: Study design purpose: Prognosis

Primary Sponsor: Universitat Bielefeld

Condition: C15 Malignant neoplasm of oesophagus

Intervention: Group 1: After inclusion in the study, the subjects will be contacted via telefphone once a year to assess overall survival and tumor progression. Annual follow-up visits are carried out un...